MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
Venture Capital: Virginia
Tall Oaks Capital
MaxCyte, Inc. (NASDAQ:MXCT)*
*Key People: Maxcyte
Parents
MaxCyte, Inc. (NASDAQ:MXCT)*
Children
2025: Rockville's MaxCyte slashes workforce by 34% amid revenue struggles
Cenk Sumen, Chief Scientific Officer, MaxCyte (2022)
Douglas Doerfler PRESIDENT & CEO, MAXCYTE, INC. (2021)
Lesley Eschinger, Director of Market Development, MaxCyte (2022)
Maher Masoud, CEO, MaxCyte (2025)
Number of employees: 125 (2022)
Sarah Meeks Vice President, Business Development, MaxCyte (2021)
Jumps
Finance & Acquisitions: Maxcyte
Organization & Developments: Maxcyte